Yerrabelly Jayaprakash Rao, Porala Subbanarasimhulu, Kasireddy Venkateshwar Reddy, Sony Earrawandla Janapriya, Sagurthi Someshswar Rao
Department of Chemistry, University College of Science, Saifabad, Osmania University, Hyderabad, Telangana 500004 India.
Department of Chemistry, Jawaharlal Nehru Technological University College of Engineering, Hyderabad, Telangana 500085 India.
Chem Zvesti. 2022;76(12):7833-7846. doi: 10.1007/s11696-022-02449-w. Epub 2022 Sep 5.
A new series of 2-aminochromone-based -di-1,2,3-triazole hybrid heterocycles were synthesized in one pot from -terminal dialkyne 2-aminochromone with various organo azides by following the click strategy using classical Cu(I)-catalyzed azide-alkyne [3 + 2] annulation reaction. The synthesized compounds were well characterized by using various spectral analyses such as IR, H NMR, C NMR, and HRMS data for their structural elucidation. All newly synthesized compounds have been investigated for anti-microbial activity against Gram-positive, Gram-negative bacteria, and fungal strains and exhibited high activity against microbial growth when compared with standard anti-bacterial agents. These derivatives were tested for anti-cancer activity against HeLa cell lines and found that all compounds exhibit good activity with IC values ranging from 0.11 to 1.04 µM than standard curcumin (IC 4.83 ± 0.44 µM). The molecular docking studies of the synthesized compounds with the affinity of ligands toward the target protein dual-specificity tyrosine-regulated kinase 2, DYRK2 (PDB id: 5ZTN) molecular docking were shown a better Moldock score performed compared to standard.
The online version contains supplementary material available at 10.1007/s11696-022-02449-w.
通过经典的铜(I)催化叠氮化物-炔烃[3 + 2]环化反应,采用点击策略,从α-末端二炔基2-氨基色酮与各种有机叠氮化物一锅法合成了一系列新的基于2-氨基色酮的α,β-二-1,2,3-三唑杂环化合物。通过红外光谱(IR)、氢核磁共振(¹H NMR)、碳核磁共振(¹³C NMR)和高分辨质谱(HRMS)等各种光谱分析对合成的化合物进行了充分表征,以阐明其结构。对所有新合成的化合物进行了针对革兰氏阳性菌、革兰氏阴性菌和真菌菌株的抗菌活性研究,与标准抗菌剂相比,它们对微生物生长表现出高活性。对这些衍生物进行了针对HeLa细胞系的抗癌活性测试,发现所有化合物均表现出良好的活性,其IC值范围为0.11至1.04 μM,优于标准姜黄素(IC为4.83±0.44 μM)。合成化合物与配体对靶蛋白双特异性酪氨酸调节激酶2(DYRK2,PDB编号:5ZTN)的亲和力的分子对接研究表明,与标准物相比,其Moldock得分更高。
在线版本包含可在10.1007/s11696-022-02449-w获取的补充材料。